A controlled trial of raloxifene (LY1394
โ
Michael W. Draper; David E. Flowers; William J. Huster; Julie A. Neild; Kristine
๐
Article
๐
2009
๐
American Society for Bone and Mineral Research
๐
English
โ 701 KB
This randomized, double-blind, placebo-controlled, multicenter, 8-week study evaluated short-term effects of raloxifene on bone turnover, serum lipids, and endometrium in healthy, postmenopausal women. A total of 251 women received either placebo, raloxifene HCl 200 or 600 mg/day, or conjugated estr